World Journal of Urology

, Volume 29, Issue 2, pp 179–184 | Cite as

Prevalence and factors associated with uncomplicated storage and voiding lower urinary tract symptoms in community-dwelling Australian men

  • Sean A. Martin
  • Matthew T. Haren
  • Villis R. Marshall
  • Kylie Lange
  • Gary A. Wittert
  • Members of the Florey Adelaide Male Ageing Study
Original Article

Abstract

Purpose

To determine the prevalence of, and associated risk factors for, voiding and storage lower urinary tract symptoms (LUTS) in a population-based sample of Australian men.

Methods

Data were collected from 1,103 men randomly selected, community-dwelling men, as part of the Florey Adelaide Male Ageing Study, after exclusion of men with prostate or bladder cancer or prior surgery to either organ. The presence of LUTS was assessed using the International Prostate Symptom Score. Urine flow was measured via flow meter. Demographic, clinical, and bio-psychosocial data were collected by questionnaire.

Results

The prevalence of total, storage, and voiding LUTS was 18.1, 28.0 and 12.6%, respectively. The most common storage symptoms were frequency (12.3%), nocturia (9.9%) and urgency (8.1%), and voiding symptoms were weak stream (8.5%), intermittency (5.4%), incomplete emptying (5.1%) and straining (2.4%). There were linear associations between storage LUTS and increased abdominal fat mass, plasma glucose and low HDL cholesterol (components of the metabolic syndrome), obstructive sleep apnoea (OSA) risk, and retirement. Voiding symptoms were associated with a previous diagnosis of benign prostatic enlargement (BPH), mean peak urine flow, total energy intake, elevated risk of OSA, erectile dysfunction, physician-diagnosed thyroid dysfunction and higher household income.

Conclusions

The close association of storage LUTS with the metabolic syndrome, and of both storage and voiding LUTS with OSA, suggest that these conditions should be considered in men presenting with LUTS.

Keywords

Prostatism/epidemiology Urinary tract physiological phenomena Cohort studies Men’s health Australia/epidemiology 

References

  1. 1.
    Mongiu AK, McVary KT (2009) Lower urinary tract symptoms, benign prostatic hyperplasia, and obesity. Curr Urol Rep 10(4):247–253PubMedCrossRefGoogle Scholar
  2. 2.
    Rohrmann S, Crespo CJ, Weber JR, Smit E, Giovannucci E, Platz EA (2005) Association of cigarette smoking, alcohol consumption and physical activity with lower urinary tract symptoms in older American men: findings from the third national health and nutrition examination survey. BJU Int 96(1):77–82PubMedCrossRefGoogle Scholar
  3. 3.
    Orsini N, Rashidkhani B, Andersson SO, Karlberg L, Johansson JE, Wolk A (2006) Long-term physical activity and lower urinary tract symptoms in men. J Urol 176(6 Pt 1):2546–2550; discussion 2550Google Scholar
  4. 4.
    Rosen RC, Giuliano F, Carson CC (2005) Sexual dysfunction and lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH). Eur Urol 47(6):824–837PubMedCrossRefGoogle Scholar
  5. 5.
    Parsons JK (2007) Modifiable risk factors for benign prostatic hyperplasia and lower urinary tract symptoms: new approaches to old problems. J Urol 178(2):395–401PubMedCrossRefGoogle Scholar
  6. 6.
    Parsons JK, Bergstrom J, Silberstein J, Barrett-Connor E (2008) Prevalence and characteristics of lower urinary tract symptoms in men aged > or = 80 years. Urology 72(2):318–321PubMedCrossRefGoogle Scholar
  7. 7.
    Roehrborn CG, Nuckolls JG, Wei JT, Steers W (2007) The benign prostatic hyperplasia registry and patient survey: study design, methods and patient baseline characteristics. BJU Int 100(4):813–819PubMedCrossRefGoogle Scholar
  8. 8.
    Coyne KS, Sexton CC, Kopp ZS, Luks S, Gross A, Irwin D, Milsom I (2009) Rationale for the study methods and design of the epidemiology of lower urinary tract symptoms (EpiLuts) study. BJU Int 104(3):348–351PubMedCrossRefGoogle Scholar
  9. 9.
    Martin S, Haren M, Taylor A, Middleton S, Wittert G (2007) Cohort profile: the Florey Adelaide male ageing study (FAMAS). Int J Epidemiol 36(2):302–306PubMedCrossRefGoogle Scholar
  10. 10.
    Pinnock C, Marshall VR (1997) Troublesome lower urinary tract symptoms in the community: a prevalence study. Med J Aust 167(2):72–75PubMedGoogle Scholar
  11. 11.
    PROS (2003) Monitoring obesity in the south australian population which survey type (telephone, face-to-face or biomedical)? North West Adelaide Health Study- Brief Reports, vol 2Google Scholar
  12. 12.
    Litman HJ, Steers WD, Wei JT, Kupelian V, Link CL, McKinlay JB (2007) Relationship of lifestyle and clinical factors to lower urinary tract symptoms: results from Boston area community health survey. Urology 70(5):916–921PubMedCrossRefGoogle Scholar
  13. 13.
    Li MK, Garcia LA, Rosen R (2005) Lower urinary tract symptoms and male sexual dysfunction in Asia: a survey of ageing men from five Asian countries. BJU Int 96(9):1339–1354PubMedCrossRefGoogle Scholar
  14. 14.
    Russell S, McVary KT (2005) Lower urinary tract symptoms and erectile dysfunction: epidemiology and treatment in the aging man. Curr Urol Rep 6(6):445–453PubMedCrossRefGoogle Scholar
  15. 15.
    Andersson SO, Rashidkhani B, Karlberg L, Wolk A, Johansson JE (2004) Prevalence of lower urinary tract symptoms in men aged 45–79 years: a population-based study of 40,000 Swedish men. BJU Int 94(3):327–331PubMedCrossRefGoogle Scholar
  16. 16.
    Jones PP, Davy KP, Alexander S, Seals DR (1997) Age-related increase in muscle sympathetic nerve activity is associated with abdominal adiposity. Am J Physiol 272(6 Pt 1):E976–E980Google Scholar
  17. 17.
    Kupelian V, McVary KT, Barry MJ, Link CL, Rosen RC, Aiyer LP, Mollon P, McKinlay JB (2009) Association of C-reactive protein and lower urinary tract symptoms in men and women: results from Boston area community health survey. Urology 73(5):950–957PubMedCrossRefGoogle Scholar
  18. 18.
    de Groat WC, Yoshimura N (2009) Afferent nerve regulation of bladder function in health and disease. Handb Exp Pharmacol 194:91–138Google Scholar
  19. 19.
    Kohler TS, McVary KT (2009) The relationship between erectile dysfunction and lower urinary tract symptoms and the role of phosphodiesterase type 5 inhibitors. Eur Urol 55(1):38–48Google Scholar
  20. 20.
    Klein JP, Waxman SG (2003) The brain in diabetes: molecular changes in neurons and their implications for end-organ damage. Lancet Neurol 2(9):548–554PubMedCrossRefGoogle Scholar
  21. 21.
    Rohrmann S, Smit E, Giovannucci E, Platz EA (2004) Association between serum concentrations of micronutrients and lower urinary tract symptoms in older men in the third national health and nutrition examination survey. Urology 64(3):504–509PubMedCrossRefGoogle Scholar
  22. 22.
    Kemmer H (2009) The relationship between sleep apnea and overactive bladder. Curr Urol Rep 10(6):448–450PubMedCrossRefGoogle Scholar
  23. 23.
    Umlauf MG, Chasens ER, Greevy RA, Arnold J, Burgio KL, Pillion DJ (2004) Obstructive sleep apnea, nocturia and polyuria in older adults. Sleep 27(1):139–144PubMedGoogle Scholar
  24. 24.
    Margel D, Shochat T, Getzler O, Livne PM, Pillar G (2006) Continuous positive airway pressure reduces nocturia in patients with obstructive sleep apnea. Urology 67(5):974–977PubMedCrossRefGoogle Scholar
  25. 25.
    Suzuki S, Platz EA, Kawachi I, Willett WC, Giovannucci E (2002) Intakes of energy and macronutrients and the risk of benign prostatic hyperplasia. Am J Clin Nutr 75(4):689–697PubMedGoogle Scholar
  26. 26.
    Haidinger G, Madersbacher S, Waldhoer T, Lunglmayr G, Vutuc C (1999) The prevalence of lower urinary tract symptoms in Austrian males and associations with sociodemographic variables. Eur J Epidemiol 15(8):717–722PubMedCrossRefGoogle Scholar
  27. 27.
    Rosen R, Altwein J, Boyle P, Kirby RS, Lukacs B, Meuleman E, O’Leary MP, Puppo P, Robertson C, Giuliano F (2003) Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging male (MSAM-7). Eur Urol 44(6):637–649PubMedCrossRefGoogle Scholar
  28. 28.
    Fliers E, Klieverik LP, Kalsbeek A (2010) Novel neural pathways for metabolic effects of thyroid hormone. Trends Endocrinol Metab 21(4):230–236Google Scholar
  29. 29.
    Ramberg H, Eide T, Krobert KA, Levy FO, Dizeyi N, Bjartell AS, Abrahamsson PA, Tasken KA (2008) Hormonal regulation of beta2-adrenergic receptor level in prostate cancer. Prostate 68(10):1133–1142PubMedCrossRefGoogle Scholar
  30. 30.
    Lehrer S, Diamond EJ, Stone NN, Droller MJ, Stock RG (2002) Serum triiodothyronine is increased in men with prostate cancer and benign prostatic hyperplasia. J Urol 168(6):2431–2433PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2010

Authors and Affiliations

  • Sean A. Martin
    • 1
  • Matthew T. Haren
    • 2
  • Villis R. Marshall
    • 1
    • 3
  • Kylie Lange
    • 4
  • Gary A. Wittert
    • 1
  • Members of the Florey Adelaide Male Ageing Study
    • 1
  1. 1.Freemasons Foundation Centre for Men’s Health, School of Medicine, Discipline of MedicineThe University of AdelaideAdelaideAustralia
  2. 2.Division of Health Sciences, SANSOM InstituteUniversity of South AustraliaAdelaideAustralia
  3. 3.Surgery and Surgical Specialties, Royal Adelaide HospitalAdelaideAustralia
  4. 4.Centre of Clinical Research Excellence in Nutritional Physiology, Interventions and Outcomes, Discipline of MedicineThe University of AdelaideAdelaideAustralia

Personalised recommendations